Nichola Hawes is on trial for alleged fraud and selling or supplying medicines without proper prescriptions.

A study finds GLP-1 weight-loss drugs may pose vision risks, revealing an unexpected medical irony. A paradoxical insight: ...

The Trump administration has promised that addressing childhood obesity will be a key part of its “Make America Healthy Again ...

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide ...

Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.

This week, the FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat: True or False: Two new trials ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the ...

Eli Lilly on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

Weight loss drugs are all the rage right now, but how long are people sticking to their regimen and continuing to shed the ...